ScinoPharm Taiwan Ltd - ESG Rating & Company Profile powered by AI
Other corporations in the rating industry group for ScinoPharm Taiwan Ltd are shown. This ESG rating covers 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Climate Action' and 'Life on Land'. This analysis of ScinoPharm Taiwan Ltd uses data from across the web as well as from public filings by ScinoPharm Taiwan Ltd.
ScinoPharm Taiwan Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.8; made up of an environmental score of 6.0, social score of 6.4 and governance score of 8.0.
6.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 294 | SMS Pharmaceuticals Ltd | 6.9 | High |
| 294 | Takeda Pharmaceutical Co Ltd | 6.9 | High |
| 314 | ScinoPharm Taiwan Ltd | 6.8 | High |
| 314 | Camurus AB | 6.8 | High |
| 314 | Cassiopea SpA | 6.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ScinoPharm Taiwan Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd report the average age of the workforce?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd offer flexible work?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd conduct supply chain audits?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose water use targets?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid ScinoPharm Taiwan Ltd have a product recall in the last two years?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ScinoPharm Taiwan Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose parental leave metrics?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ScinoPharm Taiwan Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose its waste policy?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd report according to TCFD requirements?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose energy use targets?
Sign up for free to unlockDoes ScinoPharm Taiwan Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ScinoPharm Taiwan Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ScinoPharm Taiwan Ltd
These potential risks are based on the size, segment and geographies of the company.
ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells cGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In addition, the company develops peptide synthesis technologies. Further, it develops and manufactures western medicines and other chemical materials, albumin medicines, oligonucleotide medicines, injections, and new small molecule drugs, as well as provides biological technology services and technical services. It has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. ScinoPharm Taiwan, Ltd. was incorporated in 1997 and is headquartered in Tainan City, Taiwan.